SpectaCell raises $6.0M Seed (Belgium, Oct 2026)
Reach the investors backing rounds like this
Backed by imec.xpand, PMV’s Flanders Future Tech Fund +3 more · verified emails and LinkedIn on Datapile
Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development - EU-Startups
SpectaCell is a Ghent-based startup specializing in next-generation cell therapy analytics. They have launched with €6 million in Seed funding to advance their platform, which combines digital imaging and data analysis to measure how treatments affect individual cells. The company aims to provide researchers with detailed insights faster, improving the development of immunotherapies.
Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development EU-Startups
| Oct 06, 2026 | Zymofix | $7.0M | Series A | Belgium |
| Sep 21, 2026 | Novadip Biosciences | $12.0M | Convertible | Belgium |
| Sep 18, 2026 | TUSK IC | $15.0M | Series A | Belgium |
| Sep 10, 2026 | IVEX | $5.0M | Series A | Belgium |
2,876 investors back startups in Belgium
You just read who funded SpectaCell. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.